Abstract
Abstract Background Active surveillance tests for carbapenemase-producing Enterobacteriaceae (CPE) are recommended in patients showing risk factors for colonization by these bacteria. There are limited data however on whether surveillance tests for anatomic sites other than the stool would be useful to detect CPE colonization, and we investigated this in our present study. Methods Retrospective analysis was performed on cases at our tertiary care hospital during a 5-year period. The study patients with CPE colonization had been admitted to our surgical intensive care unit (SICU) or sub-ICU for liver transplantation in this period and undergone surveillance tests for both the stool and other sites. Patients were grouped as stool CPE negative (but which included CPE positive cases from initial sputum and other site tests) or positive. Results Among the total study cohort of 158 patients, 138 (87.3%) were included in the stool CPE positive group and the remaining 20 (12.7%) in the stool CPE negative group. While the sensitivity of CPE surveillance testing of the stool was 87.3% (95% CI 81.1-92.1), the sensitivity when combining stool and sputum samples was 93.7% (88.7-96.9). The transmission rates were similar for patients showing CPE positivity in the stool, sputum and other sites, at 4.8% (27/557), 4.7% (3/64), and 6.7% (1/15), respectively (p = 0.95). Conclusion The sensitivity of CPE detection in a stool sample is suboptimal for ruling out CPE colonization and the transmission rates are similar between stool-positive or -negative cases. Combining surveillance of the stool with other sites may be needed for detecting CPE. Disclosures All Authors: No reported disclosures
Highlights
Active surveillance tests for carbapenemase-producing Enterobacteriaceae (CPE) are recommended in patients showing risk factors for colonization by these bacteria
The sensitivity of CPE detection in a stool sample is suboptimal for ruling out CPE colonization and the transmission rates are similar between stool-positive or -negative cases
Combining surveillance of the stool with other sites may be needed for detecting CPE
Summary
Active surveillance tests for carbapenemase-producing Enterobacteriaceae (CPE) are recommended in patients showing risk factors for colonization by these bacteria. Surveillance cultures are performed for the early detection of CPE colonization and to prevent additional transmission to other hospital patients The guidelines in this regard from the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend stool, rectal swab, and perirectal swab tests (e.g. for neutropenic cases) [1, 3]. CPE surveillance culture testing is routinely done in patients admitted to our surgical intensive care unit (SICU) or sub-ICU for liver transplantation These tests are conducted using sputum, urine, and the drained fluid from a biliary catheter or Jackson-Pratt (JP)/pigtail catheter, in addition to stool or rectal swabs. There are limited data on whether surveillance testing at various anatomical sites in addition to stool sampling could improve the sensitivity of CPE detection and assist with its prevention and control [5] We evaluated this possibility in our present study
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have